Loading the company…
Loading the company…
Families: Lumbar fusion, Cervical fusion & disc arthroplasty.
All companies · Product and company coverage
In the last ten years FDA made 6 decisions for Renovis Surgical Technologies (510(k) clearances, De Novo grants, PMA approvals and supplements) under the product codes MedaRep maps to 2 procedure families, the most in 2018 (3). The latest was on 2019-06-20.
| Family | Decisions on record |
|---|---|
| Lumbar fusion | 11 |
| Cervical fusion & disc arthroplasty | 2 |
| Date | Kind | Number | Device |
|---|---|---|---|
| 2019-06-20 | 510(k) | K190122 | Renovis A200 PS Knee System as part of the Renovis A200 Knee System |
| 2018-12-07 | 510(k) | K182007 | Renovis Tesera C/Tesera SC Anterior Cervical Fusion (ACF) System |
| 2018-09-11 | 510(k) | K181655 | Renovis S180 Lateral Lumbar Interbody Fusion System |
| 2018-06-14 | 510(k) | K180502 | S128 Anterior Lumbar Interbody Fusion (ALIF) System |
| 2017-11-16 | 510(k) |
| K171543 |
| Renovis Surgical Hip Replacement System |
Decisions under the product codes mapped to the procedure families; devices filed under other codes are not here. Applicants are rolled up to Renovis Surgical Technologies.